The DNAJC21 gene helps cells build ribosomes, the tiny structures that make the proteins your body needs for growth and repair. If this gene does not work properly, cells may struggle to make enough proteins, and tissues that renew quickly, especially the bone marrow, can be affected. People with disease-causing variants in the DNAJC21 gene may develop an inherited bone marrow failure condition with low blood counts, tiredness, more infections, and sometimes growth or developmental differences. This is not a gene with broad public recognition, but it is important in rare disease genetics.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or direct processes throughout the body. Some genes provide the code for proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. In combination, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. For a closer look at this topic, more information is available in the LearnHub.
Overview
DNAJC21Gene function
What if the gene works
The DNAJC21 gene helps cells build and finish ribosomes, the structures that make proteins. This supports normal cell growth and the steady renewal of tissues such as blood and the lining of the gut.
Risk
What if the gene does not work
More severe variants in the DNAJC21 gene can cause inherited bone marrow failure, often with low blood counts, infections, and poor growth. Milder variants may lead to later onset or fewer features.
Treatment
What does that mean for your treatment
No DNAJC21-specific treatment or management approach is currently established. Research is exploring how changes in the DNAJC21 gene disrupt ribosome building, which may help guide future therapies for bone marrow failure.
Conditions associated with DNAJC21
Gene function
What if the gene works
Inside your cells, the DNAJC21 gene helps with a basic job that happens all the time. It supports the making and final preparation of ribosomes, the structures that make proteins your body needs for growth, repair, and routine upkeep.
A key part of how the DNAJC21 gene helps cells make proteins is by supporting ribosome assembly. It helps prepare the larger ribosome part so it is ready for normal protein production.
DNAJC21 works with chaperones (proteins that guide other proteins) during the last steps of ribosome setup. This teamwork helps temporary assembly helpers leave at the right time.
DNAJC21 supports the handoff of a newly made ribosome part into active use in the cell. This links ribosome building to the steady flow of proteins cells need each day.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help explain normal variation among people, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not lead to any noticeable effect and are simply part of natural genetic diversity. Sometimes, however, a variant changes how a gene functions more substantially and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
How DNAJC21 gene variants affect ribosome assembly often depends on the type of change. Some variants reduce how much DNAJC21 protein the cell can make, while others alter its shape so it becomes unstable or cannot work properly during ribosome assembly (building the cell’s protein-making machinery). More disruptive variants can leave little or no working protein, while milder variants may preserve some activity, which can influence how strongly this process is affected and, in DNAJC21-related bone marrow failure, how early features appear.
How variants are linked to conditions
Pathogenic variants in the DNAJC21 gene cause a rare inherited condition called DNAJC21-related bone marrow failure syndrome. This condition is linked to low blood counts, which may show up as tiredness, infections, or easy bruising and bleeding. Some people also have short stature, growth or learning differences, and eye findings, and the condition can raise the chance of myelodysplastic syndrome or leukemia.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a role. In some situations, however, one well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the DNAJC21 gene. In families with a disease-causing DNAJC21 change, risk is mainly shaped by the inherited gene change itself, and a doctor or genetic counselor can help explain personal and family risk.
Inheritance of DNAJC21 variants
DNAJC21-related conditions are inherited in an autosomal recessive pattern. This means a person usually inherits one DNAJC21 variant from each parent, and both parents are typically healthy carriers. For families asking how DNAJC21 variants are inherited, each pregnancy between two carriers has a 25% chance of resulting in a child with the condition, a 50% chance of producing a carrier child, and a 25% chance of producing a child without the familial variants. Because the DNAJC21 gene is on an autosome, this pattern is the same for boys and girls.
What does my DNAJC21 result mean for my family?
Changes in the DNAJC21 gene are linked to a rare inherited bone marrow condition that usually runs in families in a recessive pattern. For relatives, this often means parents can be healthy carriers, and brothers or sisters may also be affected or be carriers. Other close family members may also carry the gene change, especially if there is a family history of low blood counts, poor growth, or related health problems.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the DNAJC21 gene, genetic testing for DNAJC21 variants examines DNA from a blood sample, saliva, or a cheek swab. The lab reads the gene’s sequence and looks for changes linked with inherited bone marrow conditions. Results may show a known variant, no relevant variant, or an uncertain finding.
When should I consider getting a genetic test?
Consider genetic testing for the DNAJC21 gene if there is unexplained bone marrow failure, ongoing low blood counts, or a family history of an inherited condition affecting blood cell production. Testing can help confirm whether DNAJC21 is the cause and clarify risks for relatives.
A genetic result is only one part of your health story
A genetic finding can provide meaningful information, but how much it explains depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can break down, move, or respond to a drug differently. These differences are common and can influence how strongly a medicine works or how sensitive someone is to it. Medication response also depends on other factors, including age, liver and kidney function, and other medicines a person takes.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and more personalized treatment decisions. To explore this topic in more detail, you can learn more in the LearnHub.
Drugs influenced by the DNAJC21 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects may happen. Questions about treatment, new symptoms, or medication side effects are best discussed with your doctor or pharmacist.
History
DNAJC21 entered medical genetics more recently than many well-known disease genes. In recent decades, awareness of this gene’s role has grown as researchers linked rare DNAJC21 variants to an inherited bone marrow failure condition with features that can resemble Shwachman-Diamond syndrome. Early reports connected affected families with low blood counts, growth concerns, and changes in bone marrow function, and genetic studies then pointed to the DNAJC21 gene as the shared cause. From these first observations, research expanded steadily, helping clinicians recognize DNAJC21-related disease as its own condition rather than a look-alike diagnosis. This history reflects a common pattern in genetics, where careful study of rare families gradually turns a puzzling clinical picture into a clearly defined inherited condition.